bisantrene has been researched along with Carcinoma, Squamous Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aisner, J; Fuks, JZ; Garbino, C; Kasdorf, H; Van Echo, DA | 1 |
| Crain, SM; Forastiere, AA; Garbino, C; Kasdorf, H; Perry, DJ; Tipping, SJ; Van Echo, DA | 1 |
2 other study(ies) available for bisantrene and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Treatment of advanced non-small cell lung cancer with bisantrene.
Topics: Adenocarcinoma; Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Leukocyte Count; Leukopenia; Lung Neoplasms; Male; Middle Aged | 1983 |
Phase II trial of bisantrene in advanced epidermoid carcinoma of the head and neck.
Topics: Adult; Aged; Anthracenes; Carcinoma, Squamous Cell; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Leukopenia; Male; Middle Aged; Neoplasm Recurrence, Local | 1984 |